Live Analyst Rating Changes 2217 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Justin Kim
OPCO
Justin Kim
Oppenheimer
Wall Street Analyst
★★☆☆☆
#2262
on 13Foresight · ranked by our own returns
33%
Success Rate
-8.8%
Average Return
4 of 12 calls profitable · -154.7% vs benchmark
📈 Across the calls we could measure, roughly 33% of Justin Kim's ratings turned a profit when each position was held for 1 year — averaging -8.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

3 Buy 0 Hold 0 Sell
Justin's Stock Coverage 10 ratings · 2026-06-24
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
ZURA
Zura Bio
 Jun 08, 2026 BUY Strong Buy
+239.4% avg upside
12 analysts
$16.00
271.61% Upside
 -0.4%
IONS
Ionis Pharmaceuticals
 Apr 30, 2026 BUY Strong Buy
+10.5% avg upside
43 analysts
$110.00
44.70% Upside
 -2.0%
IMCR
Immunocore Holdings
 May 08, 2025 BUY Strong Buy
+119.0% avg upside
22 analysts
$86.00
194.60% Upside
 -0.7%
CYTK
Cytokinetics
 Feb 28, 2025 BUY Strong Buy
+8.5% avg upside
36 analysts
$96.00
20.05% Upside
 +35.3%
ALDX
Aldeyra Therapeutics
 Oct 03, 2024 BUY Strong Buy
+674.8% avg upside
21 analysts
$12.00
493.99% Upside
 +9.8%
VERA
Vera Therapeutics
 Jan 26, 2024 BUY Strong Buy
+75.4% avg upside
19 analysts
$34.00
10.96% Downside
 +12.4%
PHVS
Pharvaris
 Nov 10, 2023 BUY Strong Buy
+36.1% avg upside
14 analysts
$26.00
21.69% Downside
 +28.5%
AUPH
Aurinia Pharmaceuticals
 Aug 08, 2023 HOLD Strong Buy
-13.6% avg upside
12 analysts
 — -43.7%
BCRX
BioCryst
 Dec 15, 2022 HOLD Strong Buy
+97.7% avg upside
24 analysts
 — -42.7%
ELTX
Elicio Therapeutics
 Jun 30, 2022 HOLD Buy
+362.4% avg upside
11 analysts
 — -16.7%
🔒 5 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Justin Kim — Frequently Asked Questions
How accurate are Justin Kim's stock ratings?
Based on the calls 13Foresight could measure, about 33% of Justin's ratings were profitable over a one-year hold, with an average return of -8.8% per rating, or -154.7% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Justin ranked on 13Foresight?
Justin Kim is currently ranked #2262 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Justin cover?
Justin most recently has ratings on ZURA, IONS, IMCR, CYTK, ALDX, VERA, PHVS, AUPH, BCRX, ELTX. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.